Literature DB >> 22456594

Analysis of genetic polymorphism of the HLA-B and HLA-DR loci in patients with dermatophytic onychomycosis and in their first-degree relatives.

M T García-Romero1, J Granados, M E Vega-Memije, R Arenas.   

Abstract

Onychomycosis is known to have predisposing factors and a high prevalence within families that cannot be explained by within-family transmission. We determined the frequency of HLA-B and HLA-DR haplotypes in 25 families of Mexican patients with onychomycosis in order to define the role of the class II major histocompatibility complex (MHC) in genetic susceptibility to this infection. Seventy-eight subjects participated in the study, 47 with onychomycosis and 31 healthy individuals. The frequencies of the HLA-B and HLA-DR haplotypes were compared with those found in first-degree relatives without onychomycosis and in a historic control group of healthy individuals. The frequencies in the controls were similar to those of the healthy relatives of the patients. However, on comparison of the patients with historic controls, we detected a higher frequency of the HLA-DR8 haplotype (P=.03; odds ratio, 1.89; 95% confidence interval, 0.98-36). These findings suggest that there are polymorphisms in genes of the MHC that increase susceptibility to onychomycosis, particularly haplotype HLA-DR8.
Copyright © 2010 Elsevier España, S.L. and AEDV. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22456594     DOI: 10.1016/j.adengl.2011.03.017

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  4 in total

1.  Comparative Study of Traditional Ablative CO2 Laser-Assisted Topical Antifungal with only Topical Antifungal for Treating Onychomycosis: A Multicenter Study.

Authors:  Bhavana Rajbanshi; Liangliang Shen; Miao Jiang; Qingyu Gao; Xin Huang; Jiaoyang Ma; Jihong Wang; Yang Hu; Hongli Lv; Xiao Wu; Jingjun Zhao
Journal:  Clin Drug Investig       Date:  2020-06       Impact factor: 2.859

2.  A Week of Oral Terbinafine Pulse Regimen Every Three Months to Treat all Dermatophyte Onychomycosis.

Authors:  Anarosa B Sprenger; Katia Sheylla Malta Purim; Flávia Sprenger; Flávio Queiroz-Telles
Journal:  J Fungi (Basel)       Date:  2019-09-04

3.  Associations between onychomycosis and COVID-19 clinical outcomes: a retrospective cohort study from a US metropolitan center.

Authors:  Uros Rakita; Trisha Kaundinya; Armaan Guraya; Kamaria Nelson; Brittany Maner; Jaya Manjunath; Gabrielle Schwartzman; Brittany Lane; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2021-11-12       Impact factor: 3.033

Review 4.  Advances in Understanding Human Genetic Variations That Influence Innate Immunity to Fungi.

Authors:  Richard M Merkhofer; Bruce S Klein
Journal:  Front Cell Infect Microbiol       Date:  2020-02-28       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.